Publications
|
Xiromerisiou G, Hadjigeorgiou GM, Gourbali V, Johnson J, Papakonstantinou I, Papadimitriou A, Singleton AB. Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants. Eur J Neurol 14: 7-11, 2007
(PubMed ID: 17222106)
|
|
|
LRRK2:
(Ala211Val)
(Lys544Glu)
(Gly2019Ser)
|
ID: 126 |
|
Nuytemans K, Meeus B, Crosiers D, Brouwers N, Goossens D, Engelborghs S, Pals P, Pickut B, Van den Broeck M, Corsmit E, Cras P, De Deyn PP, Del-Favero J, Van Broeckhoven C, Theuns J. Relative contributions of simple mutations versus copy number variations in five Parkinson disease genes in the Belgian population. Hum Mutat Epub: , 2009
(PubMed ID: 19405094)
|
|
|
SNCA:
(dupSNCA [N])
(IVS2+9A>C)
LRRK2:
(Leu119Pro)
(Ala211Val)
(Val366Met)
(Ala419Val)
(Arg506Gln)
(Ile1006Met)
(IVS30-6C>T)
(Arg1514Gln)
(Pro1542Ser)
(Met1646Thr)
(Gly2385Arg)
(Glu2490fs)
PARK2:
(ex2dup (breakpoints not mapped))
(ex2-3dup (breakpoints not mapped))
(ex2-12dup (breakpoints not mapped))
(ex3dup (breakpoints not mapped))
(ex3-4dup (breakpoints not mapped))
(ex3-6del (breakpoints not mapped))
(ex6del (breakpoints not mapped))
(ex6dup (breakpoints not mapped))
(Ser10Asn)
(Pro37Leu)
(Asn52fs)
(Ala82Glu)
(Met192Leu)
(Arg256Cys)
(His265Arg)
(Asn273Ser)
(Arg275Trp)
(IVS7-3C>G)
(IVS9-1G>A)
(Arg402Cys)
(Pro437Leu)
PINK1:
(Met342Ile)
PARK7:
(Lys175Glu)
(Ala179Thr)
|
ID: 25 |
Mutation color legend:
Red: mutation is pathogenic
Orange: pathogenic nature is unclear
Green: mutation is not pathogenic